PRESS RELEASE published on 01/15/2025 at 07:30, 4 months 30 days ago Inside Information / Other news releases GenSight Biologics announces the publication of 5-year outcomes for patients treated with LUMEVOQ® gene therapy, showing sustained bilateral improvement in visual acuity and favorable safety profile Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity Safety Profile
PRESS RELEASE published on 01/15/2025 at 07:30, 4 months 30 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce les résultats cliniques à 5 ans de la thérapie génique LUMEVOQ chez les patients atteints de NOHL, démontrant une amélioration bilatérale de l'acuité visuelle et un profil de sécurité favorable Thérapie Génique GenSight Biologics NOHL LUMEVOQ Résultats Cliniques
BRIEF published on 01/13/2025 at 11:31, 5 months 1 day ago Heights Capital Management exceeds 5% stake in GenSight Biologics Capital Increase Shares And Voting Rights GenSight Biologics Heights Capital Management Capital Participation
BRIEF published on 01/13/2025 at 11:31, 5 months 1 day ago Heights Capital Management dépasse 5% du capital de GenSight Biologics Augmentation De Capital GenSight Biologics Actions Et Droits De Vote Heights Capital Management Participation Capital
PRESS RELEASE published on 01/13/2025 at 11:26, 5 months 1 day ago Franchissement de seuils Déclaration de franchissement de seuils par Heights Capital Management, Inc. pour Gensight Biologics S.A. avec détention de 7 574 746 actions et 9,62% des droits de vote Déclaration Actions Franchissement De Seuils Gensight Biologics S.A. Heights Capital Management Inc.
BRIEF published on 12/24/2024 at 20:51, 5 months 21 days ago GenSight Biologics obtient un financement de 1,5 million d'euros auprès d'investisseurs existants Financement Investisseurs Thérapie Génique Mandats GenSight Biologics
BRIEF published on 12/24/2024 at 20:51, 5 months 21 days ago GenSight Biologics Secures €1.5 Million Financing from Existing Investors Investors Warrants Financing Gene Therapy GenSight Biologics
PRESS RELEASE published on 12/24/2024 at 20:46, 5 months 21 days ago Inside Information / Other news releases GenSight Biologics announces a c. €1.5 million financing from existing investors through a Reserved Offering to support gene therapy development for retinal diseases and CNS disorders Financing Gene Therapy GenSight Biologics Retinal Diseases Reserved Offering
PRESS RELEASE published on 12/24/2024 at 20:46, 5 months 21 days ago Informations privilégiées / Autres communiqués GenSight Biologics annonce un financement de 1,5 million d'euros auprès d'investisseurs existants pour le développement de thérapies géniques innovantes. Perspectives de croissance et objectifs à court terme Croissance Financement Investisseurs GenSight Biologics Thérapies Géniques
BRIEF published on 11/13/2024 at 07:35, 7 months 1 day ago GenSight Biologics dépose le dossier LUMEVOQ® auprès de l'ANSM Thérapie Génique GenSight Biologics Programme D'accès Anticipé Neuropathie Optique Héréditaire De Leber Soumission Réglementaire
Published on 06/14/2025 at 16:25, 12 hours 40 minutes ago New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
Published on 06/14/2025 at 02:00, 1 day 3 hours ago Battery X Metals Validates Provisional Patent Applications Filed with the United States Patent and Trademark Office Through Successful Real-World Trials of Next-Generation Lithium-Ion Battery Rebalancing Machine
Published on 06/14/2025 at 01:05, 1 day 4 hours ago Diamcor Receives Section 244 Notice from Tiffany & Co.
Published on 06/13/2025 at 19:10, 1 day 9 hours ago Allane Mobility Group records growth in operating business in 2024
Published on 06/13/2025 at 18:47, 1 day 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/13/2025 at 18:47, 1 day 10 hours ago Funding Circle Holdings plc: HOL-Holdings in Company - AMENDED
Published on 06/13/2025 at 18:42, 1 day 10 hours ago Funding Circle Holdings plc: HOL-Holdings in Company - AMENDED
Published on 06/13/2025 at 18:00, 1 day 11 hours ago BOA CONCEPT: Mise à disposition des documents préparatoires de l’Assemblée Générale du 26 juin 2025
Published on 06/13/2025 at 18:07, 1 day 10 hours ago Déclaration des transactions sur actions propres réalisées du 2 juin au 6 juin 2025
Published on 06/13/2025 at 18:07, 1 day 10 hours ago Disclosure of trading in own shares between June 2nd and 6th, 2025
Published on 06/13/2025 at 09:55, 1 day 19 hours ago Déclaration d'actions et de droits de vote au 31.05.2025
